228 completed, 24 unknown, 10 recruiting, 6 terminated. 106 Phase 3, 59 Phase 4, 45 Phase 2, 39 Not applicable, 21 Phase 1.
Follow Poliomyelitis: new trials by email Literature Review of Poliomyelitis trials Research Report on Poliomyelitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of BK1803 in Healthy Infants BK1803, GOBIK Aqueous Suspension Syringes, Bimmugen® Injection - Pertussis, Diphtheria | Phase 3 | Not yet recruiting | Tanabe Pharma Corporation | 344 | 2026-10-01 | 2026-08-28 |
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults Recombinant Poliomyelitis Vaccine (rPV), Inactivated Poliomyelitis Vaccine (IPOL) - Polio Immunity | Phase 1 | Recruiting | Serum Institute of India Pvt. Ltd. | 36 | 2026-09-11 | 2026-09-29 |
| A Study to Evaluate the Mucosal Intestinal Immunity to Poliovirus Type-2 of nOPV2 at Birth Dose in Healthy IPV Vaccinated Infants nOPV2 - Poliomyelitis | Phase 3 | Recruiting | Fidec Corporation | 740 | 2026-04-30 | 2026-09-09 |
| Effects of Virtual Walking on Chronic Pain and Psychological Distress for Individuals With Severe Mobility Impairment Virtaul walking, Passive observing video - Severe Mobility Impairment, Spinal Cord Injuries (SCI) | Not applicable | Active not recruiting | The Hong Kong Polytechnic University | 48 | 2026-04-02 | 2026-09-15 |
| Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease Whole-body Electrical Muscle Stimulation Exercise - Neuromuscular Diseases (NMD), Amyotrophic Lateral Sclerosis | Not applicable | Recruiting | University of Missouri-Columbia | 50 | 2026-03-10 | 2026-03-17 |
| the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Polio, Measles | Not yet recruiting | China National Biotec Group Company Limited | 600 | 2026-01-30 | 2026-01-14 | |
| Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine 2wIPV+1sIPV, 1wIPV+2sIPV, 3wIPV - Poliomyelitis | Phase 4 | Recruiting | Sinovac Biotech Co., Ltd | 480 | 2025-11-27 | 2026-03-09 |
| Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation Novel Oral Polio Vaccine Type 1 (nOPV1), Novel Oral Polio Vaccine Type 2 (nOPV2), Placebo (Sterile Water) - Poliomyelitis | Phase 2 | Recruiting | PATH | 675 | 2025-11-11 | 2026-01-09 |
| Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations sIPV, DTaP-IPV-Hib - Poliomyelitis | Phase 4 | Recruiting | Sinovac Biotech Co., Ltd | 180 | 2025-09-26 | 2026-01-21 |
| A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series LBVD, Pentavalent vaccine and Inactivated Polio vaccine - Diphtheria, Tetanus | Phase 2 / Phase 3 | Active not recruiting | LG Chem | 1186 | 2025-05-30 | 2026-09-03 |
| Study of Concomitant Administration of the sIPV and DTaP or MMR sIPV, DTaP, bOPV 1,3 - Polio, Diphteria, Tetanus and Pertussis | Phase 4 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2640 | 2025-05-15 | 2025-04-17 |
| The Impact of 'Digital Strolling' on Depression and Quality of Life of People With Severe Mobility Impairment Virtual walking, Passive observing walking - Severe Mobility Impairment, Spinal Cord Injuries (Complete and Incomplete) | Not applicable | Completed | The Hong Kong Polytechnic University | 24 | 2025-05-09 | 2026-05-19 |
| Immunogenicity of Different Primary Immunization Schedules with Inactivated Poliovirus Vaccine (IPV) Plus Pentavalent Vaccine (DTwP-HBV-Hib) or with Hexavalent Vaccine (DTwP-HBV-Hib-IPV) Pentavalent vaccine, Hexavalent vaccine, Inactivated poliovirus vaccine (IPV) - Polio | Phase 4 | Not yet recruiting | International Centre for Diarrhoeal Disease Research, Bangladesh | 1190 | 2025-01-28 | 2024-12-27 |
| A Study to Evaluate the Safety and Immunogenicity of VLP-Polio in Infants and Toddlers Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) (VLP-Polio) low adjuvant dose, VLP-Polio medium dose, VLP-Polio high dose - Poliomyelitis | Phase 1 / Phase 2 | Active not recruiting | CanSino Biologics Inc. | 480 | 2024-12-19 | 2026-08-06 |
| Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2), Novel oral poliomyelitis vaccine type 3 (nOPV3) - Poliomyelitis | Phase 1 / Phase 2 | Recruiting | PATH | 2400 | 2024-11-20 | 2025-06-03 |
| Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age LR20062, DTaP-HepB-IPV-Hib vaccine - Diphtheria, Tetanus | Phase 2 | Unknown | LG Chem | 336 | 2024-10-02 | 2024-10-01 |
| Effectiveness of Transcranial Magnetic Stimulation Treatment in Patients Diagnosed With Postpolio Syndrome Repetitive transcranial magnetic stimulation (rTMS), Sham rTMS, Individualized home exercise program - Postpolio Syndrome | Not applicable | Completed | Ege University | 28 | 2024-10-01 | 2026-09-10 |
| Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants Different immunization regiments with DTaP-IPV/Hib Pentavalent Vaccine - Pertussis, Diphtheria | Not applicable | Unknown | Jiangsu Province Centers for Disease Control and Prevention | 785 | 2024-09-05 | 2024-09-20 |
| Booster Dose of sIPV Co-administered With MMR and HepA-I. sIPV, MMR, HepA-I - Poliomyelitis | Phase 4 | Completed | Sinovac Biotech Co., Ltd | 889 | 2024-08-08 | 2026-01-16 |
| Phase IV Study of Concomitant Administration of the sIPV and HepA sIPV (booster dose at 18 months of age), HepA-L, HepA-I - Polio, Hepatitis A | Phase 4 | Not yet recruiting | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2000 | 2024-06-15 | 2024-06-14 |
Showing 20 of 283. Sign in to see all of them.
Diphtheria (113) · Tetanus (113) · Whooping Cough (80) · Haemophilus Infections (71) · Hepatitis B (68) · Postpoliomyelitis Syndrome (28) · Spinal Cord Injuries (9) · Measles (7) · Multiple Sclerosis (6) · Motor Activity (5) · Amyotrophic Lateral Sclerosis (4) · Bacterial Infections (4) · HIV Seropositivity (4) · Virus Diseases (4)
Central Nervous System Diseases (283) · Central Nervous System Infections (283) · Enterovirus Infections (283) · Myelitis (283) · Neuroinflammatory Diseases (283) · Picornaviridae Infections (283) · RNA Virus Infections (283) · Nervous System Diseases (282) · Spinal Cord Diseases (282) · Infections (281) · Neuromuscular Diseases (280) · Virus Diseases (279) · Bacterial Infections and Mycoses (118) · Gram-Positive Bacterial Infections (118) · Actinomycetales Infections (114)
Poliovirus Vaccine, Inactivated (28) · diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine (27) · Tetanus Toxoid (13) · Diphtheria-Tetanus-acellular Pertussis Vaccines (11) · Pentavac (11) · DTaP-IPV-HB-PRP-T vaccine (10) · Heptavalent Pneumococcal Conjugate Vaccine (8) · pentacel (8) · 13-valent pneumococcal vaccine (7) · RIX4414 vaccine (7) · Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (6) · Aging (5) · Poliovirus Vaccine, Oral (5) · diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine (5) · Hepatitis B Vaccines (4)
GlaxoSmithKline (44) · Sanofi Pasteur, a Sanofi Company (42) · Sanofi (15) · Sinovac Biotech Co., Ltd (15) · Centers for Disease Control and Prevention (14) · Aga Khan University (12) · Fidec Corporation (10) · LG Chem (8) · PATH (8) · Institute of Medical Biology, Chinese Academy of Medical Sciences (7) · Merck Sharp & Dohme LLC (5) · Centers for Disease Control and Prevention, China (4) · International Centre for Diarrhoeal Disease Research, Bangladesh (4) · Jiangsu Province Centers for Disease Control and Prevention (4) · National Institute of Neurological Disorders and Stroke (NINDS) (4)
China (49) · United States (27) · Bangladesh (20) · Germany (12) · France (11) · Pakistan (11) · South Korea (11) · Panama (10) · Philippines (9) · Canada (8) · Finland (8) · India (7) · Poland (7) · Dominican Republic (6) · Italy (6)
Ingrid Kromann (4) · Yuemei Hu (4) · Abhijeet Anand, MBBS, MPH (2) · Beth Kirkpatrick, M.D. (2) · Fengcai Zhu, Master (2) · Li Rongcheng, MD (2) · Orla Hardiman, BSc MB BCh BAO MD FRCPI FAAN (2) · Pauline Verdijk, PhD (2) · Zhaojun Mo, Master (2) · Zijian Feng, MD, MPH (2)
PMID 26873055, PMID 32867698, PMID 22153001, PMID 28340322, PMID 32273184, PMID 33487470, PMID 38218668, PMID 39088987, PMID 40318674, PMID 10025486, PMID 16713921, PMID 17090650, PMID 17152004, PMID 17429085, PMID 17990291, PMID 18816600, PMID 19117896, PMID 19952980, PMID 20448468, PMID 20616762, PMID 20955461, PMID 21219984, PMID 21289531, PMID 21334243, PMID 21372751, PMID 21441781, PMID 21807056, PMID 22001281, PMID 22157567, PMID 22158682, PMID 22233167, PMID 22273029, PMID 22349525, PMID 22475857, PMID 22531237, PMID 22691430, PMID 23077849, PMID 23234560, PMID 23241989, PMID 23903028, PMID 23966556, PMID 24063976, PMID 24346596, PMID 24941350, PMID 25043278, PMID 25316860, PMID 25540274, PMID 25765966, PMID 25882172, PMID 25984923
2014 (3), 2018 (2), 2009 (1), 2015 (1), 2017 (1), 2019 (1), R01NR016942 (1)